The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share. The biopharmaceutical company posted ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a ...

Ryan McKillen, the third hire at ridesharing giant Uber, bought a penthouse at One Park Grove in Miami for $22.5 million.

Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on ...

An earnings-driven stock surge for ZoomInfo (ZI) isn't stopping its founder and CEO from signing off on more aggressive share ...

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and ...

Private equity firm Bain Capital is weighing options, including a sale, for Rocket Software that could value the U.S.

Aaron Zitner is a reporter and editor in The Wall Street Journal's Washington bureau, focusing largely on how politics are driven by demographic and economic change. He also reports on trends in ...

Natalie Andrews is a White House Correspondent for The Wall Street Journal, covering domestic policy and President Trump's legislative agenda. She joined the Journal in 2014 and began covering ...

Fine, not great: Nvidia's fourth-quarter results easily beat Wall Street estimates. However, the pace of its data center revenue growth - which accounts for most of its revenue - slowed considerably.